Dr. Mustafa Mete is an ophthalmologist with over 25 years of surgical experience, specializing in advanced laser eye surgery and complex retinal treatments. As the founder of the Lumineyes™ technique, Dr. Mete has performed more than 3,000 procedures using the Lumineyes 8G Xtra dual laser system. His work in laser eye color change has been informed by more than 15 years of clinical experience and long-term patient follow-up.
Rather than viewing eye color change as a simple cosmetic treatment, Dr. Mete approaches it as a medical procedure with a cosmetic impact. His approach is based on an understanding of iris physiology, melanin distribution, and visual function. Before developing his own protocol, he studied the risks associated with invasive methods—including implants and keratopigmentation—and developed a non-incisional, melanin-targeted approach designed to work with the natural anatomy of the eye.
Beyond performing the procedure, Dr. Mustafa Mete has had the opportunity to follow many international patients over more than ten years, providing valuable long-term clinical observations regarding healing patterns, stability, and patient experience.
Note: This page focuses on Dr. Mete’s medical background and philosophy. For a technical overview of the treatment, please refer to our Lumineyes® Laser Eye Color Change Procedure guide.
The foundations of Dr. Mete’s interest in iris pigmentation and laser-based eye procedures were established during his early ophthalmology training in Türkiye. Throughout his residency and subsequent clinical experience, he worked in clinical settings that exposed him to a wide spectrum of anterior segment diseases, refractive surgery techniques, and laser-based treatments.
During his medical training, he had the opportunity to observe and collaborate with respected ophthalmologists in Türkiye, including Prof. Dr. Ömer Faruk Yılmaz, Prof. Dr. Ziya Kapran, Prof. Dr. Şükrü Bayraktar, and Prof. Dr. Vedat Kaya. These experiences contributed to his understanding of corneal and anterior segment physiology, which later informed his work on controlled iris depigmentation.
Before specializing in eye color change, he was also involved in early digital health projects, including the development of a medical information and patient-guidance website in Türkiye.
Dr. Mete achieved a national ranking in the TUS (Turkish Medical Speciality Examination), reflecting his academic performance during his medical training.
Over the years, he continued to explore different areas of ophthalmic laser applications, near-vision solutions, and corneal-based procedures. His clinical focus gradually evolved toward the study of iris pigmentation, melanin response to selective wavelengths, and the development of structured protocols for controlled eye color lightening.
Today, he provides ophthalmic consultation and eye color change assessments for patients from different regions, integrating clinical experience with a medically guided and safety-oriented approach. While the technical details of the Lumineyes® protocol are described elsewhere, his role centers on patient evaluation, risk assessment, and long-term follow-up.
The Lumineyes® concept emerged from years of observing how changes in iris pigmentation can affect light reflection, perceived color, and patient comfort. Rather than pursuing extreme or unnatural results, Dr. Mete developed a protocol that aims for a controlled, stepwise approach to iris lightening, with treatment planning adapted to each individual case.
The approach places particular emphasis on patient selection, pre-treatment evaluation, and structured follow-up. Each case is evaluated individually, taking into account iris grade, baseline pigmentation, general ocular health, and patient expectations. Eye color change is not approached as a one-size-fits-all cosmetic service; it is considered within a medical framework with defined indications and limitations.
Selective laser iris depigmentation has been explored as a method of gradually reducing superficial iris pigment density.
The Lumineyes® approach was developed by ophthalmologist Dr. Mustafa Mete as a staged clinical protocol designed to guide pigment reduction alongside ongoing ocular safety monitoring.
Rather than introducing artificial material into the eye, the approach focuses on controlled modulation of stromal pigment while maintaining the natural anatomical structure of the iris.
Eye color is not an isolated cosmetic feature; it is related to iris structure, intraocular light dynamics, and patient comfort. For this reason, Dr. Mete approaches eye color change from a medical perspective. He places strong emphasis on appropriate diagnosis, anterior segment examination, and identifying conditions that may increase risk, such as active inflammation, uncontrolled glaucoma, or significant corneal pathology.
Patients who are primarily focused on cosmetic goals are informed about alternative methods and their potential risks. Those considering intraocular procedures can review dedicated information about eye color change surgery and intraocular options, while those interested in more invasive techniques such as implants or corneal tattooing can find additional risk-based information on the website.
Whenever appropriate, conservative strategies are prioritized. If a patient is not a good candidate for laser, or if expectations are unrealistic, Dr. Mete may advise against the procedure altogether. Not every patient is considered suitable for treatment, and no specific shade is promised for every iris type.
Over time, the Lumineyes® method has been used by patients from different countries seeking a medically guided approach to eye color lightening. Patients have different goals and expectations, ranging from subtle lightening of brown eyes to hazel, green, grey, or blue-like tones. Because of this diversity, consultation places particular emphasis on education and expectation management.
For those comparing laser with other approaches, the website provides separate information about corneal-based procedures such as keratopigmentation for eye color change and the risks associated with artificial color iris implants. Another resource discusses why more heavily pigmented eyes may require additional sessions and why treatment planning should remain conservative; this is covered in the page on eye color change procedure cost and risks.
Patients who prefer to first understand natural variations and non-surgical factors that can affect the appearance of eye color can also explore the educational resources available on the website before considering any procedure.
The Lumineyes® approach is informed by the broader scientific literature on iris pigmentation, melanin photothermolysis, and anterior segment safety. While laser-based eye color change remains a specialized area, its underlying principles draw on established concepts in ophthalmic and dermatologic laser applications.
Patients are encouraged to explore independent sources of information, including:
These external resources do not endorse any specific cosmetic procedure. They provide broader scientific context for the ophthalmic and laser principles considered in Dr. Mete’s clinical work.
A key part of his role is to say no when necessary. There are situations where any form of eye color change, whether laser-based or surgical, may carry excessive risk compared with potential benefit. Examples include uncontrolled ocular disease, untreated inflammation, severe dry eye, structural abnormalities of the iris, or unrealistic expectations.
In such cases, the safest option may be to avoid intervention entirely. For those who still wish to understand alternative techniques and their documented complications, the website provides information about both laser-based and intraocular methods without encouraging unsafe experimentation.
Patients may consider MyLumineyes® not only because they are interested in changing their eye color, but also because they want to understand the procedure, its limitations, and the alternatives available to them.
The website provides:
The goal is not to recommend a single procedure to every patient, but to provide information that supports an individualized and medically considered decision.
If you are considering an eye color change, the first step is a careful assessment of your general eye health, iris structure, and expectations. A consultation allows Dr. Mete to review your medical history, examine your eyes, and determine whether you might be a candidate for a laser-based approach or whether another option — including no intervention at all — would be more appropriate.
After this assessment, you may be directed to additional resources on the website, including information about alternative procedures, risk explanations, and photographic examples of realistic outcomes. These materials are designed to complement, not replace, a personalized clinical evaluation.
High School: Kadikoy Anatolian High School
Medical Degree: Doctor of Medicine (MD), Uludag Medical University
Residency: Ophthalmology, Beyoglu Eye Research & Education Hospital
Turkish Medical Association
Landesärztekammer Hessen-Germany
Beyoglu Eye Research & Education Hospital
Medicalpark Hospital
Medicana Hospital
Kayagoz Eye Center
Dunyagoz Eye Hospital
Batigoz Eye Hospital
Consultant Ophthalmologist in Europe
Dr. Mustafa Mete, an ophthalmologist focusing on iris pigmentation and anterior segment procedures, developed the Lumineyes® approach as a staged clinical method for selective laser iris depigmentation.
The Lumineyes method is a medically monitored protocol designed to gradually reduce superficial iris pigment density using controlled laser energy, while preserving the natural anatomy of the iris.
Laser iris depigmentation is considered a medical procedure affecting the anterior segment of the eye. Patient selection, monitoring, and staged treatment protocols are essential for safety.
Dr Mustafa Mete evaluates patients seeking eye color change through the Lumineyes approach and provides consultations for individuals interested in medically supervised iris depigmentation procedures.
Lumineyes Assistant
×
